Remove 2029 Remove Communication Remove Pharmaceutical Companies
article thumbnail

COPD market to reach $30.8 billion in 7MM by 2033: GlobalData

Express Pharma

Other KOLs have communicated that Dupixent is to dominate the biologics market after receiving both EMA and FDA approval, filling a gap in the COPD market. The changes made by GOLD have communicated that ICS/LABA fixed-dose combinations should not be used, which has been reflected in the COPD report, highlighting a 1.4 billion by 2033.”

article thumbnail

EHDS regulation will depend on strong patient confidence

Pharmaceutical Technology

Communication between European Union (EU) member states is ongoing to finalise the details of the legislation, but at its core, the EHDS will provide a single registry of patient data from across the continent. The regulation came into force in March 2025; however, it has not yet come into application, with this set to happen in March 2029.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. Using digital means we can streamline communications, facilitate better patient engagement, and ultimately improve retention rates.

article thumbnail

AI in Life Sciences: Exploring Innovation and Opportunities

Viseven

in 2029 , with a compound annual growth rate of 27.9%. In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. In life sciences, chatbots and virtual assistants can be used by pharmaceutical companies to improve communication with patients.